VBB assists Gedeon Richter for its acquisition of all shares in Estetra and Neuralis from Mithra Pharmaceuticals
- 24/06/2024
- News
Sincere congratulations to our long-standing client Gedeon Richter for its acquisition of all shares in Estetra and Neuralis from Mithra Pharmaceuticals.This transaction secures the long-term perennity of Mithra’s key asset, the own-developed lead platform based on Estetrol (E4), a unique, native estrogen. It also secures the employment of the current members of personnel of Estetra and Neuralis and various members of personnel of Mithra. This represents a unique opportunity for Gedeon Richter to further expand and deepen its presence in its core Women’s Healthcare (WHC) business worldwide.
The transaction was one of the first large pre-pack procedures under Belgian law, and the first one involving a listed entity. The transaction also introduced various innovative solutions and can be considered a successful application of the new pre-pack procedure.
Our transactions team assisted Gedeon Richter, in close cooperation with many of our specialised lawyers. Corporate M&A partner Michel Bonne, assisted by corporate M&A associates Stefania Sacuiu, Andreas Wuylens and Sarah Arens, received the great assistance of our life sciences, competition and FDI, employment law, finance and commercial law colleagues to bring this transaction to a successful close.
